Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Net Income towards Common Stockholders: 2022-2025

Historic Net Income towards Common Stockholders for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$48.2 million.

  • Gossamer Bio's Net Income towards Common Stockholders fell 56.55% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.2 million, marking a year-over-year increase of 5.12%. This contributed to the annual value of -$56.5 million for FY2024, which is 68.56% up from last year.
  • As of Q3 2025, Gossamer Bio's Net Income towards Common Stockholders stood at -$48.2 million, which was down 31.61% from -$36.6 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Net Income towards Common Stockholders peaked at -$30.8 million during Q3 2024, and registered a low of -$59.0 million during Q3 2022.
  • For the 3-year period, Gossamer Bio's Net Income towards Common Stockholders averaged around -$42.1 million, with its median value being -$41.9 million (2024).
  • Per our database at Business Quant, Gossamer Bio's Net Income towards Common Stockholders surged by 32.23% in 2023 and then crashed by 56.55% in 2025.
  • Gossamer Bio's Net Income towards Common Stockholders (Quarterly) stood at -$57.2 million in 2022, then grew by 15.85% to -$48.1 million in 2023, then spiked by 31.40% to -$33.0 million in 2024, then tumbled by 56.55% to -$48.2 million in 2025.
  • Its Net Income towards Common Stockholders was -$48.2 million in Q3 2025, compared to -$36.6 million in Q2 2025 and -$39.3 million in Q1 2025.